Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Patients post-ASCT on Len maint with sustained MRD negativity for >6 mos have superior 3-year PFS vs. those without sustained MRD measured by NGF (100% vs. 67.6%; HR 0.06; P<0.007) and NGS (90.5% vs. 72.2%; HR 0.23; P=0.048).”

“Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study”

Authors: Takeshi Yoroidaka, Hiroyuki Takamatsu, Ryota Urushihara, Mitsuhiro Itagaki, Satoshi Yoshihara, Tadao Ishida, Kenshi Suzuki, Hirokazu Murakami, Brian Durie, Kazuyuki Shimizu et al.

Myeloma Paper of the Day, April 17th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.